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1 |  INTRODUCTION
Sustained monomorphic ventricular tachycardia (SMVT) 
is a well‐described complication in coronary artery disease 
(CAD) but is an uncommon initial finding in the setting of 
acute myocardial infarction (AMI). We present a case of 
SMVT as the initial presentation of an anterior ST‐eleva-
tion myocardial infarction (STEMI) in a previously healthy 
individual.
2 |  CASE REPORT
During a recreational orienteering race, a 69‐year‐old man 
with no previous history of heart disease developed sudden 
chest pain and malaise. As symptoms persisted, emergency 
medical services were called, and an ambulance dispatched. 
Within 90  minutes of the debut of symptoms, paramedics 
arrived. At first medical contact, the patient had ongoing 
chest pain but did not report palpitations or syncope. The 
patient denied having experienced cardiac symptoms before, 
did not have a family history of cardiovascular disease and 
was a never‐smoker without a history of excessive alcohol 
consumption. Vital signs were stable apart from tachycar-
dia at a rate of 157 beats per minute. A 12‐lead ECG was 
recorded demonstrating SMVT (Figure 1). The patient was 
treated with 300  mg aspirin, 0.4  mg glyceryl nitrate, and 
70 µg fentanyl at the site. As the patient was awake and as-
sessed hemodynamically stable, prehospital cardioversion 
was not performed.
Upon admission to hospital the SMVT persisted and as 
the patient was now hypotensive with a blood pressure of 
92/69 mm Hg acute cardioversion using a single 200‐joule 
biphasic shock was performed. After the restoration of sinus 
rhythm, the chest pain persisted, and a new 12‐lead ECG was 
obtained revealing pronounced anterior ST elevation and a 
right bundle branch block (Figure 2) that was not present on 
a ECG from the patient recorded 2  years prior (Figure 3). 
Urgent cardiac catheterization was performed demonstrating 
single vessel disease in a right dominant system with an acute 
proximal left anterior descending (LAD) occlusion that were 
treated with primary percutaneous coronary intervention 
(PPCI) (Figure 4).
Following successful revascularization, SMVT recurred 
and 300  mg amiodarone was administered intravenously. 
Since the arrhythmia persisted and as the patient experienced 
loss of consciousness, cardiopulmonary resuscitation with 
DC‐cardioversion was initiated resulting in termination of 
the SMVT with a return of spontaneous circulation time of 
<1 minute.
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Abstract
Traditionally sustained monomorphic ventricular tachycardia (SMVT) is associated 
with areas of myocardial scar such as that of chronic coronary artery disease. We 
present a case of SMVT in the initial setting of an acute myocardial infarction in a 
previously healthy individual suggesting that acute ischemia can give rise to SMVT.
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Following PPCI and resuscitation, the patient was fully 
awake and aware but with symptoms of slight chest dis-
comfort and nausea. Vital signs were stable, and a new 12‐
lead ECG was recorded demonstrating sinus rhythm with 
resolved ST elevations. Echocardiography was performed 
showing septo‐apical hypokinesia with reduced left ven-
tricular ejection fraction (LVEF) of 40% but was other-
wise normal without signs of left ventricular hypertrophy 
or valve disease (Figure 5). Initial cardiac troponin T was 
only mildly elevated at 23 ng/L (reference range 0‐14 ng/L) 
while plasma potassium, sodium and creatinine levels were 
within normal limits. Repeat measurement of cardiac tropo-
nin T the following day showed significantly elevated lev-
els at 7510 ng/L consistent with AMI. Telemetry during the 
first 24 hours displayed sinus rhythm with multiple episodes 
of accelerated idioventricular rhythm and nonsustained 
ventricular tachycardia that was treated acutely with two 
doses of metoprolol 50  mg. No further tachyarrhythmias 
were observed. Cardiac magnetic resonance imaging (MRI) 
with stress perfusion was performed demonstrating LVEF 
of 43% and signs of a fresh anterior AMI with edema and 
late gadolinium enhancement in the anteroseptal and apical 
F I G U R E  1  ECG at first medical contact showing sustained monomorphic ventricular tachycardia
F I G U R E  2  ECG after cardioversion showing anterior ST elevation (red arrows) and reciprocal ST depression (blue arrows)
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parts of the left ventricle. No other areas with infarction or 
reversible ischemia were found (Figure 6). After 5 days of 
observation and telemetry in a coronary ward, the patient 
was discharged.
3 |  FOLLOW‐UP
Following discharge, the patient was implanted with a 
1‐chamber implantable cardioverter‐defibrillator (ICD) 
12 days after the index event and referred to an outpatient 
heart failure clinic where he was up‐titrated in anti‐conges-
tive medication. At 6 months from index event, no further 
sustained tachyarrhythmias have been recorded from the ICD 
and repeat echocardiography has demonstrated normaliza-
tion of left ventricular systolic function with LVEF of 55%. 
The patient is asymptomatic and has resumed participating in 
orienteering races.
4 |  DISCUSSION
Ventricular tachycardia (VT) and ventricular fibrillation (VF) 
are important complications in both acute and chronic CAD. 
Traditionally acute ischemia is thought to give rise to VF, 
occasionally preceded by polymorphic VT, whereas SMVT 
is associated with chronic CAD where surviving myocardial 
cells in the border zone of a healed infarction is able to serve 
as a substrate for reentry.1-5
In this report, we present a case of SMVT as the initial 
presentation of STEMI in a previously healthy individual. 
This suggests that SMVT can develop and persist in the 
F I G U R E  3  ECG from 2 years prior to index event
F I G U R E  4  Left hand panel shows an 
acute coronary angiogram with a proximal 
LAD occlusion (*). The right hand panel 
shows the LAD after PCI (white arrows)
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setting of extensive acute ischemia in the absence of a known 
pre‐existing substrate. While the possibility of antecedent oc-
cult CAD in the patient cannot be ruled out, there are several 
conditions that reduce the likelihood of this being the case. 
The patient did not report of any cardiac symptoms prior to 
the event despite regular strenuous exercise, had a normal 
ECG from 2 years past, and cardiac MRI with stress perfu-
sion and LGE did not reveal other areas with ischemia or pre-
vious infarction.
Based on the surface ECGs, the exact nature of the 
SMVT cannot be established. A possible mechanism could 
be macro‐reentry with the large ischemic parts of the 
ventricle containing areas of slow conduction and block 
mimicking the electrophysiological properties of myocar-
dial scar. Other possible mechanisms could be focal such 
as increased automaticity combined with the mechanical 
stretching of the ischemic areas of the left ventricle, and a 
high sympathetic tone that participation in the orienteer-
ing race might also have contributed to. At admittance to 
hospital, the plasma potassium levels of the patient were 
within normal limits, but had hypokalemia been present 
this could have increased the likelihood of triggering and 
sustaining the SMVT.
The observation that SMVT can occur in previously 
healthy individuals in the setting of acute ischemia is in 
line with a study from Hatzinikolaou‐Kotsakou et al6 where 
SMVT was found in 0.6% of patients within the first 6 hours 
of AMI. This incidence is echoed in a similar study from 
Mont et al7 where 0.8% of patients developed SMVT within 
the first 4 hours of AMI; however, this study did not exclude 
patients with previous CAD. In both studies, patients were 
treated with thrombolysis and the occurrence of SMVT was 
found associated with extensive infarction size, predomi-
nantly anterior of origin as the case in our patient. In a more 
recent study by Hai et al8 where patients treated with PCI 
were included, SMVT was found in 3.3% of the study pop-
ulation however this incidence was within the first 2  days 
of AMI rather than within the first hours. Only few studies 
examining the incidence of ventricular tachyarrhythmias in 
STEMI before PPCI as in the present case report exist.9,10 
These suggest a VT/VF incidence of 0.4%‐3.0% but do not 
differentiate between SMVT and VF let alone polymorphic 
VT.
5 |  CONCLUSION
In rare cases, sustained monomorphic VT can be the initial 
presentation of an AMI in previously healthy individuals.
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F I G U R E  5  Left hand panel shows a end‐diastolic parasternal long axis echo image. No left ventricular hypertrophy or valve disease was 
found. Right hand panel shows a end‐systolic apical 4 chamber view with anteroseptal hypokinesia (white arrow)
F I G U R E  6  MRI scan showing large anteroseptal myocardial 
infarction (white arrows)
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